Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Update

Revelation Biosciences, Inc. (NASDAQ:REVBW) was the target of a significant decline in short interest in the month of December. As of December 31st, there was short interest totaling 79,979 shares, a decline of 51.1% from the December 15th total of 163,692 shares. Based on an average daily volume of 46,288 shares, the short-interest ratio is currently 1.7 days. Based on an average daily volume of 46,288 shares, the short-interest ratio is currently 1.7 days.

Revelation Biosciences Trading Down 2.3%

Shares of NASDAQ REVBW traded down $0.00 on Thursday, reaching $0.01. 1,100 shares of the company traded hands, compared to its average volume of 16,683. The company has a 50 day moving average of $0.01 and a 200 day moving average of $0.01. Revelation Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.02.

Revelation Biosciences Company Profile

Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.

The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.